Development pharmaceutics for veterinary medicinal products - Scientific guideline

This document provides guidance on the data from pharmaceutical development studies required for marketing authorisation of veterinary medicinal products. It applies to pharmaceuticals produced by chemical synthesis.

Keywords: Development pharmaceutics, formulation, quality, product, dosage form, veterinary medicinal product (VMP)

Current effective version

Guideline on development pharmaceutics for veterinary medicinal products

Adopted Reference Number: EMA/CVMP/QWP/684556/2022 Legal effective date: 17/02/2023

Document history

Note for guidance: Development pharmaceutics for veterinary medicinal products

Adopted Reference Number: EMEA/CVMP/315/98 - Final Legal effective date: 01/03/2000